Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

被引：152
作者：
Azizi, M [1 ]
Ménard, J [1 ]
机构：
[1] Hop Europeen Georges Pompidou, INSERM, Assistance Publ Hop Paris, Clin Invest Ctr 9201, F-75908 Paris 15, France
来源：
CIRCULATION | 2004年 / 109卷 / 21期
关键词：
angiotensin; renin; heart failure; hypertension; kidney;
D O I：
10.1161/01.CIR.0000131449.94713.AD
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2492 / 2499
页数：8
相关论文
共 71 条
[1]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[2]   CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS [J].
ANDERSON, S ;
MEYER, TW ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) :612-619
[3]   Additive effects of losartan and enalapril on blood pressure and plasma active renin [J].
Azizi, M ;
Guyene, TT ;
Chatellier, G ;
Wargon, M ;
Menard, J .
HYPERTENSION, 1997, 29 (02) :634-640
[4]   Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations [J].
Azizi, M ;
Bissery, A ;
Bura-Rivière, A ;
Ménard, J .
JOURNAL OF HYPERTENSION, 2003, 21 (10) :1887-1895
[5]   ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES [J].
AZIZI, M ;
CHATELLIER, G ;
GUYENE, TT ;
MURIETAGEOFFROY, D ;
MENARD, J .
CIRCULATION, 1995, 92 (04) :825-834
[6]   Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[7]   Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients [J].
Azizi, M ;
Linhart, A ;
Alexander, J ;
Goldberg, A ;
Menten, J ;
Sweet, C ;
Ménard, J .
JOURNAL OF HYPERTENSION, 2000, 18 (08) :1139-1147
[8]   Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure [J].
Baruch, L ;
Anand, I ;
Cohen, IS ;
Ziesche, S ;
Judd, D ;
Cohn, JN .
CIRCULATION, 1999, 99 (20) :2658-2664
[9]  
Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941
[10]  
Bonnet F, 2001, DIABETOLOGIA, V44, P874
12345678